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Abstract 
Purpose: We have observed an increasing incidence of myelodysplastic syndromes 
(MDS) in the geographic area of Western Greece during the past two decades. The 
objective of this study was to investigate potential risk factors for the manifestation of 
MDS in this area of Greece. 
Methods: A hospital-based case-control study was conducted in the public hospitals of 
the region. Participants were interviewed based on a questionnaire regarding 
demographics, occupational exposures, smoking, alcohol consumption, dietary and 
domestic factors. 
Results: A total of 228 individuals (126 cases, 102 controls) were recruited in this 
study. Univariate analysis showed that risk of MDS was associated with a family 
history of hematologic malignancy or solid tumor, exposure to pesticides, insecticides, 
herbicides, increased weekly intake of meat and eggs, and increased alcohol intake, 
whereas fruit intake had a protective effect. Analysis by pesticide ingredient showed a 
weak association of exposure to paraquat and glyphosate with the occurrence of MDS. 
Multivariate analysis showed that independent risk factors for the manifestation of 
MDS were family history of solid tumor (OR 2.47, 95% CI 1.32-4.65), meat intake for 
≥ 5 days/week (OR 2.67, 95% CI 1.05-6.80) and exposure to pesticides (OR 3.25, 95% 
CI 1.73-6.11).  
Conclusions: Exposure to pesticides is a major risk factor of MDS in Western Greece. 
Family history of solid tumor and increased meat intake also appear to play a role in 
the pathogenesis of MDS. Public health authorities should implement policies to advise 
and protect farmers from the harmful effects of agrochemicals. Emphasis should also 
be given to health promotion advice including healthy eating.  
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Comorbidities 
 
Introduction 
The incidence of MDS increases with age and it varies significantly among 
different countries. Ageing carries an increased risk for different types of cancer, and it 
is well-recognized that previous chemotherapy or radiation therapy predispose to 
therapy-related MDS (t-MDS) [1]. Among other factors that have been studied, 
benzene and ionizing radiation have been clearly proven to be carcinogenic to the 
hematopoietic system [2]. Many other occupational exposures have been suspected to 
play a role, but most frequently data are insufficient for a definite conclusion. During 
the past years there has been an increasing interest in investigating the role of smoking, 
as well as the potential harm from the use of agricultural chemicals.  
The administrative region of Western Greece consists of three prefectures: 
Achaia, Ilia and Etolia-Akarnania, and has a population of 679,796 inhabitants 
according to 2011 census. We have conducted a retrospective epidemiological study on 
the incidence of MDS in this region, during the period 1990-2009, which revealed an 
increasing trend for diagnosing an MDS. This was mainly attributed to an increase of 
RA and RARS, whereas the incidence of RAEB and CMML remained rather stable 
over the study period [3]. The observed increasing trend in the incidence of MDS in 
Western Greece led us to search for potential risk factors in this particular region. 
Therefore, the objective of the present study was to investigate the role of 
occupational, environmental, dietary and lifestyle factors in the pathogenesis of MDS 
in this geographic area.  
 
Patients and methods 
1. Study population 
A hospital-based case-control study was conducted for the purposes of this 
research. The group of cases consisted of prevalent de novo MDS patients, who 
attended the Hematology outpatient clinic at the University Hospital of Patras and at 
“St Andrew” General Hospital of Patras in Western Greece. Only patients with a 
confirmed diagnosis of MDS, according to FAB classification [4] after bone marrow 
examination, were included in the study. Patients with a previous history of 
chemotherapy or radiation therapy were not included.  
 4 
 
The group of controls consisted of patients admitted to the Ophthalmology 
Department of the University Hospital of Patras, to undergo elective operation for 
cataract. Patients with a history of hematological disorder and/or previous 
chemotherapy or radiotherapy were excluded from the group of controls. Proportional 
matching of cases and controls was performed by gender and age.  
Both cases and controls were interviewed based on the same questionnaire. 
Interviews were conducted in hospital by medical doctors, between November 2009 
and July 2013. The questionnaire included:  
a) Demographic data, such as gender, age, area of residence, years of education, 
marital status and profession  
b) Family history of hematologic malignancy or solid tumor in the first degree relatives  
c) Agricultural activities, exposure to agricultural chemicals, i.e. pesticides, 
insecticides, herbicides, fertilizers, and frequency of exposure. As regularly exposed 
were considered those who were using agrochemicals regularly as part of their routine 
agricultural practice. Rarely exposed were those who did not make use of pesticides 
routinely but only occasionally or under special circumstances. Indirectly exposed 
were those who did not use agrochemicals themselves but had been working with 
somebody else using them. When the individual reported exposure to pesticides, they 
were asked to recall brand names of the products they had been exposed to.  
d) Exposure to a list of occupational risk factors  
e) Nutritional factors 
f) Smoking and alcohol intake 
g) Domestic factors 
h) Leisure activities and hobbies, and 
i) Exposure to ionizing radiation for diagnostic purposes.  
All individuals gave their informed consent to participate in the study. The 
protocol was approved by the Scientific and Ethical Committees of the two 
participating hospitals. 
 
2. Statistical analysis 
Statistical analysis was performed with IBM SPSS Statistics 22.0. T-test was 
used for the comparison of means and independent samples t-test for the comparison 
between groups. Pearson’s chi-square test was used for the comparison of percentages 
among groups. Logistic regression was performed to assess the impact of different 
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variables on the risk for MDS, by calculating odds ratio (OR) and its 95% confidence 
intervals (95% CI). Univariate analysis was initially performed for each factor 
separately. Variables with a p value <0.10 as well as matching variables (age and 
gender) were finally included in the multivariate analysis (via forward conditional 
method). P<0.05 was considered to be statistically significant unless otherwise 
specified.  
 
Results 
1. Demographic data 
Totally 228 subjects participated in the study (126 cases and 102 controls). 
Mean age at the time of interview and gender distribution were not significantly 
different between the two groups. Cases and controls did not differ significantly by 
years of education (reflecting socioeconomic status), residence in a rural or urban area 
or marital status. More than half of the individuals in both groups were farmers (66% 
of cases and 56% of the controls) (primary or secondary occupation) (Table 1).  
 
2. Exposure to potential risk factors – Univariate analysis  
2.1. Family history of cancer  
Patients with MDS reported a family history of hematologic malignancy (OR 
3.56, 95% CI 1.15-11.02) or solid tumor (OR 2.46, 95% CI 1.39-4.36) more often than 
controls (Table 2).  
 
2.2. Occupational risk factors 
Patients with MDS were more frequently exposed to pesticides, compared to 
controls (OR 2.47, 95% CI 1.44-4.24). In particular, they were more frequently 
exposed to insecticides (OR 3.34, 95% CI 1.62-6.90) and herbicides (OR 2.27, 95% CI 
1.14-4.51), whereas exposure to fungicides was not significantly different between 
cases and controls. Patients were consequently stratified into three groups, according to 
the frequency of their general exposure to pesticides (never, rarely, regularly exposed). 
People who were rarely (N=23) or indirectly exposed (N=7) were grouped together in 
stratified univariate analysis. The association was statistically significant, both in the 
group of low frequency and in the group of high frequency. There was also weak 
evidence suggesting that use of fertilizers may be associated with MDS (Table 2). The 
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use of protective measures during application did not seem to modify the risk of MDS 
among the exposed (p=0.254).   
Among the 228 individuals, it was possible to identify status of exposure to 
certain pesticides in 185 of them. After analyzing these qualitative data we managed to 
match reported brand names to a list of pesticide ingredients (Table 3). In certain cases 
the individuals could not recall the actual names, therefore analysis was restricted to 
the ones that were confirmed.  
Analysis by name of pesticide was done only for those encountered more 
frequently. Exposure to paraquat dichloride (Gramoxone) was associated with MDS 
(OR 4.90, 95% CI 1.05-22.75). There was also weak evidence that exposure to 
glyphosate (Roundup) may be associated with MDS (OR=2.57, 95% CI 0.96-6.84) 
(Table 2).   
All cases and controls were interviewed, regarding exposure to dyes, colors, 
glues, veneers, greases, oil, gasoline, heavy metals, plastics, welding fumes, wood 
processing, carbon, sulphuric acid, carbon tetrachloride, acetone, turpentine, textile 
industry, and other occupational risk factors, but none of them was found to differ 
significantly between the two groups. However, for the majority of the above 
occupational factors the number of exposed individuals was very low (Table 2). In 
particular, the OR of exposure to tar, liquid gas, asbestos, steel dust, dry cleaning 
fumes, methanol, ionizing radiation, and electromagnetic radiation could not be 
calculated because the number of exposed individuals was 0 in either group of cases or 
controls.  
 
2.3. Dietary factors 
Diagnosis of MDS was associated with the consumption of meat for ≥ 5 days a 
week (OR 3.20, 95% CI 1.39-7.41) and of >2 eggs per week (OR 2.09, 95% CI 1.08-
4.05). There was also weak evidence suggesting that consumption of dairy products 
more often than 5 days a week may be associated with MDS (OR 1.65, 95% CI 0.92-
2.97). On the other hand, consumption of fruit more often than 5 days a week had a 
protective effect (OR 0.56, 95% CI 0.31-0.99). Finally, no difference in the weekly 
consumption of vegetables, fish, legumes and coffee between cases and controls was 
observed (Table 4).  
 
2.4. Smoking and alcohol consumption 
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In the present study, no significant association between smoking and risk of 
MDS was found, even when current and former smokers were grouped together as 
ever-smokers (Table 5). 
Regarding alcohol consumption, it was shown that the risk of MDS for those 
consuming ≥ 15 drinks (alcohol equivalents) per week was 2-fold higher, in 
comparison to those who consumed 0-14 drinks per week (OR 2.06, 95% CI 1.13-
4.11). There was not sufficient evidence to prove any association between MDS and 
the kind of drink that had been consumed (wine, beer or spirits). Further analysis of a 
possible interaction between smoking and alcohol consumption did not show any 
significant results. However, a joint effect of smoking with exposure to pesticides was 
observed (OR 2.89, 95% CI 1.35-6.22) (Table 6).  
 
2.5. Domestic, environmental risk factors, leisure activities and stressful life events 
The participants of the study were interviewed on hair dye use, type of 
residence, proximity of residence with petrol station, with a mobile antenna, use of 
microwave oven, cordless or mobile phone, and use of computer, but none of these 
factors was significantly different between cases and controls. We also studied the use 
of domestic insecticides, as well as hobbies (gardening, wood preservation, 
preservation of car or motorbike, amateur use of coloring), but no significant 
difference was shown between cases and controls. Individuals were also interviewed 
briefly on their experience of any stressful life events. The prevalence of stressful life 
events in general was not different between cases and controls. There was weak 
evidence of an increased risk of MDS in those who had experienced loss or severe 
illness of a child, and reduced risk in those who had lost their spouse (Table 7). 
 
2.6. Exposure to ionizing radiation for diagnostic purposes  
No difference was shown between cases and controls regarding exposure to X-
rays, computerized tomography (CT) scan, scintigram, mammogram, angiography, 
barium swallow, barium enema and intravenous pyelogram (Table 7). 
  
3. Multivariate analysis of risk factors for MDS 
In the multivariate analysis we included the matching variables (gender and 
age), as well as all variables for which p value was <0.10 in the univariate analysis. 
Hence, the following parameters were included in the analysis: gender, age, family 
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history of hematologic malignancy, family history of solid tumor, exposure to 
pesticides, exposure to fertilizers, alcohol consumption, weekly consumption of meat, 
eggs, dairy products, fruit and vegetables. Types of agricultural chemicals (i.e. 
herbicides, insecticides) as well as the frequency of exposure were not included in the 
multivariate analysis, because they had already been taken into account by including 
general exposure to pesticides. 
Multivariate analysis showed that the following three variables were 
independently associated with the risk of MDS: family history of solid tumor (OR 
2.47, 95% CI 1.32-4.65), consumption of meat ≥ 5 days a week (OR 2.67, 95% CI 
1.05-6.80), and exposure to pesticides (OR 3.25, 95% CI 1.73-6.11) (Table 8).  
 
4. Myelodysplastic syndromes and comorbidities 
Presence of other comorbid conditions was retrieved from medical records and 
confirmed during the interview. Such data were available for 200/228 participants 
(88%), and were missing for 11/126 cases (9%) and 17/102 controls (17%). 
Remarkably, history of osteoarthritis (OR 0.20, 95% CI 0.09-0.46), allergy (OR 0.20, 
95% CI 0.08-0.54) and hypertension (OR 0.44, 95% CI 0.24-0.77) appeared to have a 
negative association with MDS (Table 9).  
 
Discussion 
 The etiology of de novo MDS is unknown and probably multifactorial. This 
study attempted to investigate a wide spectrum of potential risk factors, most but not 
all of which had previously been reported in the literature. 
Few studies have demonstrated an association of MDS with family history of 
hematologic malignancy [5,6] or other cancer [7]. In the present study we did find a 
significant association between MDS and family history of hematologic malignancy or 
solid tumor. Notably, the latter was confirmed as an independent risk factor in 
multivariate analysis. This finding implies the importance of genetic predisposition for 
cancer and deserves further investigation in large epidemiological studies.    
Whereas cases and controls were similarly involved in farming and other 
agricultural activities, exposure to pesticides (and particularly herbicides and 
insecticides) was significantly associated with MDS, and this proved to be an 
independent risk factor in multivariate analysis. Exposure to agricultural chemicals has 
been studied extensively as a risk factor, and most studies indicate a positive 
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association with MDS [6,7,8,9,10,11,12], although in some others, no significant 
association was found [13,14]. A recent meta-analysis of 11 case-control studies 
confirmed a significant association between MDS and exposure to pesticides. 
Increased risk was also associated with exposure to insecticides, but not to herbicides 
or fungicides [15]. In another meta-analysis, exposure to pesticides was associated with 
the manifestation of other hematologic malignancies, and, in a stratified analysis, 
association was only found with non-Hodgkin lymphoma (NHL), whereas results for 
leukemia and multiple myeloma were borderline significant [16]. In addition, another 
meta-analysis has also shown a significant association between occupational exposure 
to pesticides and myeloid leukemia [17]. Apart from hematologic malignancies, 
exposure to pesticides has been associated with solid tumors, such as brain, breast, 
pancreatic, prostate, and stomach cancer [18].  
Among types of pesticides associated with carcinogenesis are the following [19]: 
1. Organochlorine insecticides, such as: 
a) DDT (4,4'-Dichlorodiphenyltrichloroethane): classified by the International 
Agency for Research on Cancer (IARC) as possibly carcinogenic (Class 2B) since 
1991 but recently upgraded to Class 2A (probably carcinogenic) [20,21]. 
b) Chlordane: classified as Class 2B (possibly carcinogenic) [20].  
c) Lindane: recently reviewed by IARC and upgraded from Class 2B (possibly 
carcinogenic) to Class 1 (carcinogenic) [21], linked specifically to NHL [22]. 
2. Organophosphate insecticides: such as Dichlorvos (DDVP), classified as Class 
2B (possibly carcinogenic) [20]. 
3. Herbicides such as 2,4-D (2,4-dichlorophenoxyacetic acid), recently classified 
as possibly carcinogenic (class 2B) [21], and glyphosate (isopropylamine salt): 
recently classified by IARC as Class 2A (probably carcinogenic) [20]. 
In our study we found an increased risk of MDS in subjects exposed to glyphosate, 
although not statistically significant. We also found an association of MDS with 
exposure to paraquat. A prospective cohort in the US reported an association between 
exposure to paraquat and NHL, as well as a non-significantly elevated relative risk for 
leukemia [23].  
Occupational exposure to many other risk factors has been previously 
investigated, and MDS has been associated with exposure to radiation, organic 
substances, metals (copper) and hydrogen peroxide [13], exposure to organic solvents 
[5,6,24], petroleum and textile dust [5]. In the present study the participants were 
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interviewed on history of exposure to potential occupational risks, but no significant 
association with MDS was observed. However, the total number of exposed persons 
was really low in the studied population, and it might not have been possible to reveal 
such an association even if it really existed. This is mainly explained by the fact that 
Western Greece is a rather agricultural than industrial region.  
   The role of diet in MDS is still obscure. In our study cases consumed meat and 
eggs more often than controls, and controls consumed fruit more often than cases. 
Among these, only consumption of meat for ≥5 days a week proved to be an 
independent risk factor in multivariate analysis. A large cohort study revealed obesity 
as a risk factor for MDS, whereas participation in vigorous physical activity had a 
protective role. In the same cohort, no association was found between MDS and meat, 
fruit or vegetable intake [25]. Another study found a positive association of MDS with 
coffee intake [7], whereas coffee intake was not different between cases and controls in 
our study. A case-control study conducted in China showed that tea consumption has a 
protective role against MDS [26]. 
  In the present study, no significant association was revealed between smoking 
and MDS. Smoking has been studied thoroughly as a risk factor for myelodysplasia in 
many studies. Most of them revealed a significant association of smoking with MDS 
[9,25,28,29,30], whereas others did not [8,13,27]. A meta-analysis confirmed that 
smoking plays an important role in the occurrence of MDS [32]. Finally, another study 
showed that alcohol intake and smoking jointly increased the risk of MDS, whereas 
each of these factors alone had limited effect [33]. In our study there was weak 
evidence that the effect of smoking was enhanced by drinking alcohol, even though the 
result was not significant. Nevertheless, we found that the combination of smoking and 
exposure to pesticides increased the risk for MDS. This joint effect has been reported 
by Strom et al [6]. In a case-control study conducted in Thessaly, central Greece, it was 
shown that smoking during pesticide application increased the risk of MDS and other 
hematologic malignancies [12].  
Smoking is considered to be the main non-occupational source of exposure to 
benzene, which is longtime known for its leukemogenic effect in humans [34,35]. A 
number of studies have investigated the impact of smoking on the cytogenetics of 
patients with MDS, and some of them have found a positive association between 
smoking and abnormal karyotype [6,36]. Abnormal karyotype has also been 
investigated in relation to occupational exposure in some studies [36,37,38]. 
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 In the present study the consumption of ≥15 drinks-alcohol equivalents per 
week was associated with increased risk of MDS. Alcohol consumption has been 
addressed as a risk factor for MDS, with some studies showing a positive association 
[7,27] and some others not [31].  
Hair dye use has been reported to be associated with a significantly increased 
risk of MDS in some [9,24] but not all [37] studies, but no association was confirmed 
in our study. Among the leisure activities studied, none was found to be associated 
with an increased risk of MDS. West et al studied the role of ionizing radiation for 
diagnostic purposes and found that exposure to dental X-rays and possibly bone X-rays 
was associated with MDS [13].  On the contrary, Nisse et al did not find such an 
association [5]. In our study we did not find a significant impact of the number of 
radiology investigations, however the sample was small and this question is probably 
subject to recall bias.  
To our knowledge, the role of stressful life events in MDS has not been 
explored. Stressful life events have been linked with other types of cancer (e.g. breast 
cancer [39]). Stress can affect different pathways of the immune system [40]. In our 
study we did not find an overall difference in reported stressful life events between 
cases and controls. However, cases had more frequently suffered loss or severe illness 
of their child, whereas controls had experienced more often death of their spouse.  A 
study with a larger number of participants and more detailed interrogation on perceived 
stress could probably shed more light on this unexplored aspect of MDS pathogenesis.  
Finally, multivariate analysis showed that exposure to pesticides, increased 
meat intake and family history of cancer were independent risk factors for MDS in 
Western Greece.  
Despite the small number of participants, we attempted to compare 
comorbidities between cases and controls. We found a higher prevalence of 
hypertension, allergy and osteoarthritis in the group of controls. Few studies have 
studied the association of MDS with other diseases. Dalamaga et al found an 
association between MDS and autoimmune thyroid disease [41], and another study 
with data from the General Practice Research Database showed a slightly increased 
risk of MDS in patients diagnosed with any autoimmune disorder more than 10 years 
before diagnosis of MDS [42]. MDS have also been associated with other comorbid 
conditions, such as Crohn’s disease [43], Helicobacter pylori infection [44] and HIV 
infection [45,46]. 
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The limitations of the present study are mainly related to its nature. As a case-
control study, information was collected retrospectively and there may be a recall bias, 
as many exposures happened decades before. One methodological pitfall in similar 
studies is that MDS patients may try harder than controls to attribute their disease to 
some factors, thus increasing the recorded exposure rate in the group of cases. 
Additionally, the interviewer was not blinded as to the case/control status of the 
participants. The number of participants was relatively small. A larger number of 
participants would increase statistical power and it might have allowed more 
associations to be revealed. Prevalent (not incident) cases of MDS were recruited and 
some of the conditions may have slightly changed since the date of diagnosis. For 
instance, the nutrition of patients with MDS may have been modified due to anemia or 
other laboratory findings, and the answers given may not reflect their dietary habits 
before diagnosis. Finally, information was obtained in a face-to-face interview and not 
by a self-administered questionnaire. Therefore, it is not known whether the 
participants replied honestly, especially regarding alcohol consumption or stressful life 
events. However, the present study could not have been realized otherwise, given that 
patients were elderly and more than half of them had only primary education. 
All of the above underline the complexity of mechanisms involved, and imply 
that the pathogenesis of MDS is multifactorial. Given the increasing bulk of evidence, 
it is mandatory to minimize occupational and environmental exposure to 
agrochemicals. Public health authorities should implement policies in order to advise 
and protect farmers from the harmful effects of exposure to pesticides. Emphasis 
should be given on health promotion, smoking cessation, maintaining a healthy diet 
and psychological well-being.  
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Table 1. Demographics of cases and controls.  
 
Variable Group N Controls Cases p value  
Gender Men  159 69 90 
0.537 (ns) 
 Women  69 33 36 
Area of residence Rural 125 54 71 
0.607 (ns) 
 Urban 103 48 55 
Years of education 0   14 7 7 
0.985 (ns) 
 1-6  127 57 70 
 7-9   31 13 18 
 10-12   27 13 14 
 >12   26 12 14 
 Unknown   3 0 3 
Marital status Married 173 81 92 
0.505 (ns) 
 Single   8 2 6 
 Divorced   4 1 3 
 Widower  43 18 25 
Profession Farmer (1
st
 occupation)  92 31 61  
 Farmer (2
nd
 occupation)  48 26 22  
 Farmers (total) 140 57 83 
0.123 (ns) 
 Non-farmers  88 45 43 
Mean age (standard deviation) [range] 
 75.3 
(6.69) 
[56-88] 
75.2 
(7.98) 
[53-93] 
0.915 (ns) 
Total  102 126  
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Table 2. Family history of hematologic and other malignancy and exposure to occupational risk factors (univariate analysis). 
 
Variable Category N Controls Cases OR 95% CI p value  
Family history of hematologic malignancy No 208 98 110 1.00  (Ref.) 
0.027 
 Yes 20 4 16 3.56 1.15-11.02 
Family history of solid tumor No 147 77 70 1.00  (Ref.) 
0.002 
 Yes 81 25 56 2.46 1.39-4.36 
Agricultural activities No 71 36 35 1.00  (Ref.) 
0.224 (ns) 
 Yes 157 66 91 1.42 0.81-2.49 
Pesticides No 122 67 55 1.00  (Ref.) 
0.001 
 Yes 106 35 71 2.47 1.44-4.24 
Frequency of exposure to pesticides Never 122 67 55 1.00  (Ref.) 
0.005  Rarely/Indirectly 30 10 20 2.44 1.05-5.64 
 Regularly 76 25 51 2.48 1.37-4.51 
Fungicides No 172 75 97 1.00  (Ref.) 
0.541 (ns) 
 Yes 26 13 13 0.77 0.34-1.77 
Insecticides No 148 76 72 1.00  (Ref.) 
0.001 
 Yes 50 12 38 3.34 1.62-6.90 
Herbicides No 148 73 75 1.00  (Ref.) 
0.019 
 Yes 50 15 35 2.27 1.14-4.51 
Fertilizers No 152 72 80 1.00  (Ref.) 
0.073 
 Yes 49 16 33 1.86 0.94-3.65 
Glyphosate No 162 77 86 1.00  (Ref.) 
0.060 
 Yes  23  6 17 2.57 0.96-6.84 
Paraquat No 172 81 91 1,00  (Ref.) 
0.043 
 Yes  13  2 11 4.90 1.05-22.75 
Propineb No 171 74 97 1.00  (Ref.) 
0.138 (ns) 
 Yes  14  9  5 0.42 0.14-1.32 
Deltamethrin No 176 80 96 1.00  (Ref.) 
0.480 (ns) 
 Yes   9  3  6 1.67 0.40-6.88 
Colors No 202 93 109 1.00  (Ref.) 
0.273 (ns) 
 Yes 26 9 17 1.61 0.69-3.79 
Dyes No 203 94 109 1.00  (Ref.) 
0.180 (ns) 
 Yes 25 8 17 1.83 0.76-4.44 
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Veneers No 213 95 118 1.00  (Ref.) 
0.876 (ns) 
 Yes 15 7 8 0.92 0.32-2.63 
Glues No 219 99 120 1.00  (Ref.) 
0.487 (ns) 
 Yes 9 3 6 1.65 0.40-6.77 
Gasoline No 198 91 107 1.00  (Ref.) 
0.342 (ns) 
 Yes 30 11 19 1.47 0.66-3.25 
Oil Νο 205 90 115 1.00  (Ref.) 
0.451 (ns) 
 Yes 23 12 11 0.72 0.30-1.70 
Greases No 204 89 115 1.00  (Ref.) 
0.329 (ns) 
 Yes 24 13 11 0.65 0.28-1.53 
Heavy metals No 221 98 123 1.00  (Ref.) 
0.507 (ns) 
 Yes 7 4 3 0.60 0.13-2.73 
Plastics No 221 99 122 1.00  (Ref.) 
0.919 (ns) 
 Yes 7 3 4 1.08 0.24-4.95 
Welding fumes No 225 101 124 1.00  (Ref.) 
0.692 (ns) 
 Yes 3 1 2 1.56 0.15-18.22 
Wood processing No 226 99 123 1.00  (Ref.) 
0.793 (ns) 
 Yes 6 3 3 0.77 0.16-4.07 
Carbon  No 226 101 125 1.00  (Ref.) 
0.881 (ns) 
 Yes 2 1 1 0.81 0.05-13.08 
Sulphuric acid No 225 101 124 1.00  (Ref.) 
0.692 (ns) 
 Yes 3 1 2 1.63 0.15-18.22 
Carbon tetrachloride No 226 101 125 1.00  (Ref.) 
0.881 (ns) 
 Yes 2 1 1 0.81 0.05-13.08 
Acetone No 225 101 124 1.00  (Ref.) 
0.692 (ns) 
 Yes 3 1 2 1.63 0.15-18.22 
Turpentine No 224 101 123 1.00  (Ref.) 
0.438 (ns) 
 Yes 4 1 3 2.46 0.25-24.05 
Textile industry No 222 98 124 1.00  (Ref.) 
0.289 (ns) 
 Yes 6 4 2 0.39 0.07-2.20 
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Table 3. Pesticide ingredients and number of individuals who reported a specific 
exposure in our study.   
 
Ingredient IARC classification  N 
Herbicides   
Glyphosate Group 2A  23 
Paraquat not listed 13 
Fluazifop-P-butyl not listed 1 
Simazine Group 3  1 
Propanil not listed 2 
   
Insecticides   
0.05% Pyrethrins, 0.4% Permethrin, 
0.1% Pyripoxyfen 
Permethrin classified in Group 3 
(other ingredients not listed) 
5 
Deltamethrine Group 3 9 
DDT (dichlorodiphenyltrichloroethane) Group 2A 2 
Methamidophos not listed 4 
Endosulfan Group 2A 1 
Demeton-O + demeton-S, mercaptophos not listed 2 
Methamidophos not listed 1 
Sodium arsenate  Group 1 2 
Morphothion (organophosphate) not listed 3 
Dimethoate (organophosphate) not listed 2 
Fenthion (organophosphate) not listed 1 
Malathion (organophosphate) Group 2A 1 
Carbofuran (carbamate) not listed 1 
Methomyl (carbamate) not listed 1 
Lindane (organochlorine) 1 1 
Aldrin (organochlorine) 3 1 
   
Fungicides   
Propineb not listed 14 
Metalaxyl-Μ, mancozeb not listed 5 
 
IARC Classification groups 
Group 1 Carcinogenic to humans 
Group 2A Probably carcinogenic to humans 
Group 2B         Possibly carcinogenic to humans 
Group 3 Not classifiable as to its carcinogenicity to humans             
Group 4 Probably not carcinogenic to humans 
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Table 4. Nutritional factors (univariate analysis). 
Food Frequency N Controls Cases OR  95% CI p value  
Meat 0-4 days/week 193 94 99 1.00  (Ref.) 
0.006 
 5-7 days/week 35 8 27 3.20 1.39-7.41 
Eggs 0-2 /week 176 86 90 1.00  (Ref.) 
0.029 
 3-7 /week 51 16 35 2.09 1.08-4.05 
Dairy products 0-5 days /week 63 34 29 1.00  (Ref.) 
0.091 
 6-7 days /week 164 68 96 1.65 0.92-2.97 
Fruit 0-5 days /week 71 25 46 1.00  (Ref.) 
0.048 
 6-7 days /week 156 77 79 0.56 0.31-0.99 
Vegetables  0-5 days /week 94 37 57 1.00  (Ref.) 
0.157 (ns) 
 6-7 days /week 133 65 68 0.68 0.40-1.16 
Fish 0-2 days /week 194 90 104 1.00  (Ref.) 
0.287 (ns) 
 3-7 days /week 33 12 21 1.51 0.71-3.25 
Legumes 0-1 days /week 163 70 93 1.00  (Ref.) 
0.389 (ns) 
 ≥ 2 days /week 65 32 33 0.78 0.44-1.38 
Coffee 0-1 /day 134 57 77 1.00  (Ref.) 
0.425 (ns) 
 ≥ 2 /day 94 45 49 0.81 0.47-1.37 
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Table 5. Smoking and alcohol consumption (univariate analysis). 
 
Variable Category N Controls Cases OR 95% CI p value 
Smoking (1) Never  91 43 48 1.00 (Ref.) 
0.521 (ns)  Current smokers  45 22 23 0.94 0.46-1.91 
 Ex-smokers 92 37 55 1.33 0.74-2.39 
Smoking (2) Never 91 43 48 1.00 (Ref.) 
0.534 (ns) 
 Ever-smokers 137 59 78 1.18 0.69-2.02 
Alcohol use  0-14 drinks/week 173 85 88 1.00 (Ref.) 
0.019 
 ≥ 15 drinks/week 55 17 38 2.06 1.13-4.11 
Wine No 58 27 31 1.00 (Ref.) 
0.748 (ns) 
 Yes 170 75 95 1.10 0.61-2.01 
Beer No 184 81 103 1.00 (Ref.) 
0.657 (ns) 
 Yes 44 21 23 0.86 0.44-1.66 
Spirits No 164 72 92 1.00 (Ref.) 
0.685 (ns) 
 Yes 64 30 34 0.89 0.50-1.58 
Kind of drink No alcohol 47 20 27 1.00 (Ref.) 
0.914 (ns) 
 Wine only 94 42 52 0.92 0.45-1.86 
 Beer only 3 2 1 0.37 0.03-4.37 
 Spirits only 6 4 2 0.37 0.06-2.22 
 Wine + beer 20 8 12 1.11 0.38-3.22 
 Wine + spirits 37 15 22 1.09 0.45-2.60 
 Beer + spirits 2 1 1 0.74 0.09-12.57 
 Wine + beer + 
spirits 
19 10 9 
0.67 0.23-1.94 
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Table 6. Exploring the joint effect smoking/alcohol consumption and 
smoking/pesticide exposure (univariate analysis). 
 
Variable Category N Controls Cases OR 95% CI p value 
Smoking and 
alcohol use 
Never-smoker and 
no alcohol 
29 14 15 1.00 (Ref.) 
0.093 
(ns)  
 Never-smoker and  
1-14 drinks per week 
51 27 24 0.83 0.33-2.07 
 Never smoker and     
≥ 15 drinks per week 
11 2 9 4.20 0.77-22.91 
 Ever-smoker and no 
alcohol 
15 4 11 2.57 0.66-9.96 
 Ever-smoker and 1-
14 drinks per week 
78 40 38 0.88 0.38-2.08 
 Ever smoker and      
≥ 15 drinks per week 
44 15 29 1.80 0.69-4.71 
Smoking and 
pesticide 
exposure 
Never smoker and 
not exposed to 
pesticides 
50 29 21 1.00 (Ref.) 
0.011 
 Never smoker and 
exposed to pesticides 
41 14 27 2.66 1.13-6.27 
 Ever-smoker and not 
exposed to pesticides 
72 38 34 1.24 0.60-2.56 
 Ever-smoker and 
exposed to pesticides 
65 21 44 2.89 1.35-6.22 
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Table 7. Domestic and environmental factors and exposure to diagnostic procedures (univariate analysis). 
 
Variable Frequency N Controls Cases OR 95% CI p value 
Hair dye 
No 198 86 112 1.00 (Ref.) 
0.312 (ns) 
Yes 30 16 40 0.67 0.31-1.45 
Type of residence 
House 184 79 105 1.00 (Ref.) 
0.187 (ns) 
Block of flats 42 22 20 0.68 0.35-1.34 
Proximity of residence to 
petrol station 
No 202 93 109 1.00 (Ref.) 
0.187 (ns) 
Yes 25 8 17 1.81 0.75-4.39 
Proximity of residence to 
mobile antenna 
No 213 97 116 1.00  (Ref.) 
0.225 (ns) 
Yes 14 4 10 2.09 0.64-6.87 
Microwave oven 
No 179 79 100 1.00  (Ref.) 
0.833 (ns) 
Yes 48 22 26 0.93 0.49-1.77 
Cordless phone 
No 125 63 62 1.00  (Ref.) 
0.304 (ns) 
Yes 68 29 39 1.37 0.75-2.48 
Mobile phone 
No 122 51 71 1.00  (Ref.) 
0.340 (ns) 
Yes 106 51 55 0.77 0.46-1.31 
Use of computer 
No 220 100 120 1.00  (Ref.) 
0.386 (ns) 
Yes 7 2 5 2.03 0.40-10.97 
Domestic insecticides 
No 101 49 52 1.00  (Ref.) 
0.275 (ns) 
Yes 126 52 74 1.34 0.79-2.27 
Gardening 
No 105 52 53 1.00  (Ref.) 
0.395 (ns) Rarely 33 14 19 1.33 0.60-2.93 
Often (≥1 weekly) 90 36 54 1.47 0.83-2.60 
Hobby related with 
dyes/coloring 
No 206 92 114 1.00 (Ref.) 
0.943 (ns) 
Yes 22 10 12 0.97 0.40-2.34 
Wood preservation 
No 216 96 120 1.00 (Ref.) 
0.707 (ns) 
Yes 12 6 6 0.80 0.25-2.56 
Preservation of 
car/motor bike 
No 216 96 119 1.00 (Ref.) 
0.916 (ns) 
Yes 13 6 7 0.94 0.31-2.89 
Stressful event 
No 134 57 77 1.00 (Ref.) 
0.384 (ns) 
Yes 93 45 48 0.79 0.46-1.34 
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Type of stressful event 
None 133 57 76 1.00 (Ref.) 
0.013 
Death/severe illness of child 25 7 18 1.93 0.75-4.93 
Death of spouse 31 22 9 0.31 0.13-0.72 
Other 38 16 22 1.03 0.50-2.14 
X-rays 0-9 125 56 69 1.00 (Ref.) 
0.978 (ns)  10-19 54 25 29 0.94 0.50-1.79 
 ≥ 20 45 20 25 1.01 0.51-2.01 
CT scan 0 92 41 51 1.00 (Ref.) 
0.421 (ns)  1 78 39 39 0.80 0.44-1.47 
 ≥ 2 57 22 35 1.28 0.65-2.51 
Scintigram 0 181 80 101 1.00 (Ref.) 
0.659 (ns) 
 ≥ 1 44 22 24 0.86 0.45-1.65 
Mammogram 0 190 83 107 1.00  (Ref.) 
0.392 (ns) 
 ≥ 1 37 19 18 0.73 0.36-1.49 
Barium swallow 0 209 96 113 1.00  (Ref.) 
0.390 (ns) 
 ≥ 1 18 6 12 1.70 0.61-4.70 
Barium enema 0 216 98 118 1.00  (Ref.) 
0.560 (ns) 
 ≥ 1 11 4 7 1.45 0.41-5.11 
Angiogram 0 190 85 105 1.00  (Ref.) 
0.892 (ns) 
 ≥ 1 37 17 20 0.95 0.47-1.93 
Intravenous pyelogram 0 221 97 124 1.00  (Ref.) 
0.093 (ns) 
 1 6 5 1 0.16 0.02-1.36 
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Table 8. Multivariate analysis: independent risk factors for MDS.  
 
Variable Category OR  95% CI p value  
Family history of solid tumor  No 1.00  (Ref.) 
0.005 
 Yes 2.47 1.32-4.65 
Consumption of meat  0-4 days a week 1.00  (Ref.) 
0.040 
 ≥ 5 days a week 2.67 1.05-6.80 
Exposure to pesticides No 1.00  (Ref.) 
<0.0001 
 Yes 3.25 1.73-6.11 
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Table 9. Comorbidities in cases and controls (univariate analysis). 
  
Comorbidity  Category N Controls Cases OR  95% CI p value  
Allergy No 176 67 109 1.00  (Ref.) 
0.001 
 Yes 24 18 6 0.20 0.08-0.54 
Autoimmune disease No 188 82 106 1.00  (Ref.) 
0.218 (ns) 
 Yes 12 3 9 2.32 0.61-8.85 
Hypertension No 94 30 64 1.00  (Ref.) 
0.005 
 Yes 106 55 51 0.44 0.24-0.77 
Ischemic heart disease No 171 76 95 1.00  (Ref.) 
0.181 (ns) 
 Yes 29 9 20 1.78 0.77-4.13 
Heart failure No 187 82 105 1.00  (Ref.) 
0.156 (ns) 
 Yes 13 3 10 2.60 0.69-9.77 
Stroke No 190 82 108 1.00  (Ref.) 
0.418 (ns) 
 Yes 10 3 7 1.77 0.44-7.06 
Atrial fibrillation No 175 79 96 1.00  (Ref.) 
0.052 (ns) 
 Yes 25 6 19 2.61 0.99-6.84 
Diabetes mellitus No 154 65 89 1.00  (Ref.) 
0.878 (ns) 
 Yes 46 20 26 0.95 0.49-1.85 
Thyroid disease No 178 75 103 1.00  (Ref.) 
0.766 (ns) 
 Yes 22 10 12 0.87 0.36-2.13 
Peptic ulcer No 184 78 106 1.00  (Ref.) 
0.916 (ns) 
 Yes 16 7 9 0.95 0.34-2.65 
Osteoarthritis No 166 60 106 1.00  (Ref.) 
<0.0001 
 Yes 34 25 9 0.20 0.09-0.46 
Parkinson’s disease No 195 82 113 1.00  (Ref.) 
0.432 (ns) 
 Yes 5 3 2 0.48 0.08-2.96 
Psychiatric disease No 176 74 102 1.00  (Ref.) 
0.725 (ns) 
 Yes 24 11 13 0.86 0.36-2.02 
Neoplasm No 185 81 104 1.00  (Ref.) 
0.155 (ns) 
 Yes 16 4 12 2.34 0.73-7.51 
COPD No 182 80 102 1.00  (Ref.) 
0.193 (ns) 
 Yes 18 5 13 2.04 0.70-5.96 
 
